This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Donna Rill
Chief Technology Officer at Triumvira Immunologics


Ms. Rill is currently serves as the Chief Technical officer of Triumvira Immunologics, USA, Inc. She has extensive manufacturing, clinical and translational research laboratory experience in cell and gene therapy, monoclonal antibody production, and protein production. She has setup and managed core development laboratories covering a large range of testing services to facilitate research, core drug development activities as well as manufacturing and quality control laboratories. With her expertise in the areas of laboratory construction, project management, development and operations, cGMP, cGTP, and GLP regulatory compliance, quality control/assurance system, database development,  and clinical standards of practice, she has designed and qualified cGMP Cell & Gene Therapy Laboratories, cGMP Vector Production facilities, core service laboratories, and Translational Research Labs.

Ms. Rill has previously held the positions of Vice President of Manufacturing for Cell Medica, Chief Development Officer for Opexa Therapeutics, Laboratory Director of Cell and Gene Therapy, Translational Research Laboratories for Cell and Gene Therapy, Baylor College of Medicine; Associate Scientist/Lab Manager of the Bone Marrow Transplant Research Laboratory, and the GMP Cell & Gene Therapy Laboratories, St. Jude Children’s Research Hospital; Education Coordinator and Clinical Instructor, Department of Clinical Laboratory, LeBonheur Children's Medical Center and University of Tennessee Center for the Health Sciences.

Agenda Sessions

  • PANEL DISCUSSION: Spinning out from Academia and Ensuring early stage success

    On Demand